Linda Pissott Reig, Shareholder in Buchanan's FDA & Biotechnology practice, is leading BioNJ's Legal, Compliance & Regulatory Forum on November 3 at Novartis Pharmaceuticals in East Hanover, NJ. The program addresses the hurdles and opportunities associated with the approval and uptake of biosimilars in the U.S. market. She will also co-moderate a discussion titled "A Day in the Life of a Biosimilar: A Case Study," which will detail current trends in FDA regulatory oversight, recent biosimilar case law updates, market access challenges and opportunities, and disruptors in the marketplace. Learn more.
View Linda's PowerPoint presentation by clicking the link in the sidebar under Resources.